Long-Term Alcohol Consumption Caused a Significant Decrease in Serum High-Density Lipoprotein (HDL)-Cholesterol and Apolipoprotein A-I with the Atherogenic Changes of HDL in Middle-Aged Korean Women.
alcohol
apolipoproteins A-I
high-density lipoproteins
low-density lipoproteins
paraoxonase
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Aug 2022
03 Aug 2022
Historique:
received:
22
06
2022
revised:
29
07
2022
accepted:
02
08
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
Light-to-moderate alcohol drinking is associated with a low incidence of cardiovascular disease (CVD) via an elevation of high-density lipoproteins-cholesterol (HDL-C), particularly with the short-term supplementation of alcohol. However, there is no information on the change in the HDL qualities and functionalities between non-drinkers and mild drinkers in the long-term consumption of alcohol. This study analyzed the lipid and lipoprotein profiles of middle-aged Korean female non-drinkers, mild-drinkers, and binge-drinkers, who consumed alcohol for at least 10 years. Unexpectedly, the serum levels of HDL-C and apolipoprotein A-I (apoA-I) were decreased significantly depending on the alcohol amount; the binge-drinker group showed 18% and 13% lower HDL-C (p = 0.011) and apoA-I levels (p = 0.024), respectively, than the non-drinker group. Triglyceride (TG) and oxidized species, malondialdehyde (MDA), and low-density lipoproteins (LDL) levels were significantly elevated in the drinker groups. Interestingly, the binge-drinker group showed 1.4-fold higher (p = 0.020) cholesterol contents in HDL2 and 1.7-fold higher (p < 0.001) TG contents in HDL3 than those of the non-drinker group. The mild-drinker group also showed higher TG contents in HDL3 (p = 0.032) than the non-drinker group, while cholesterol contents were similar in the HDL3 of all groups. Transmission electron microscopy (TEM) showed that the non-drinker group showed a more distinct and clear particle shape of the LDL and HDL image with a larger particle size than the drinker group. Electrophoresis of LDL showed that the drinker group had faster electromobility with a higher smear band intensity and aggregation in the loading position than the non-drinker group. The HDL level of binge drinkers showed the lowest paraoxonase activity, the highest glycated extent, and the most smear band intensity of HDL and apoA-I, indicating that HDL quality and functionality were impaired by alcohol consumption. In conclusion, long-term alcohol consumption in middle-aged women, even in small amounts, caused a significant decrease in the serum HDL-C and apoA-I with atherogenic changes in LDL and HDL, such as an increase in TG and MDA content with a loss of paraoxonase activity.
Identifiants
pubmed: 35955766
pii: ijms23158623
doi: 10.3390/ijms23158623
pmc: PMC9369027
pii:
doi:
Substances chimiques
Apolipoprotein A-I
0
Cholesterol, HDL
0
Triglycerides
0
Ethanol
3K9958V90M
Cholesterol
97C5T2UQ7J
Aryldialkylphosphatase
EC 3.1.8.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Age Ageing. 2011 Jul;40(4):423-9
pubmed: 21624928
Arch Toxicol. 2016 Oct;90(10):2349-67
pubmed: 27353523
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
J Lipid Res. 2002 Aug;43(8):1264-74
pubmed: 12177170
J Nutr. 2006 Apr;136(4):877-81
pubmed: 16549444
Int J Mol Sci. 2022 Apr 02;23(7):
pubmed: 35409326
Metabolism. 2007 Jul;56(7):947-53
pubmed: 17570257
Clin Chim Acta. 1996 Mar 15;246(1-2):39-49
pubmed: 8814968
Circulation. 2000 Nov 7;102(19):2347-52
pubmed: 11067787
J Lipid Res. 1968 Nov;9(6):693-700
pubmed: 4176473
Nutrients. 2015 Nov 05;7(11):9116-26
pubmed: 26556367
J Clin Invest. 1977 Sep;60(3):546-54
pubmed: 561118
Physiol Res. 2015;64(Suppl 3):S371-5
pubmed: 26680670
Med Sci (Basel). 2021 May 24;9(2):
pubmed: 34074048
Am J Clin Nutr. 2017 Apr;105(4):905-912
pubmed: 28251934
Anal Biochem. 1978 Jun 15;87(1):206-10
pubmed: 98070
J Clin Endocrinol Metab. 2011 Apr;96(4):885-93
pubmed: 21474685
J Biol Chem. 2001 Feb 16;276(7):4804-11
pubmed: 11067853
BMJ. 1999 Dec 11;319(7224):1523-8
pubmed: 10591709
Crit Rev Clin Lab Sci. 2002 Jun;39(3):225-83
pubmed: 12120782
Antioxidants (Basel). 2021 Oct 21;10(11):
pubmed: 34829522
Am J Clin Nutr. 2004 Jul;80(1):217-24
pubmed: 15213051
Eur Heart J. 2021 Dec 14;42(47):4791-4806
pubmed: 34472586
Nutrients. 2020 Mar 27;12(4):
pubmed: 32230720
BMC Med. 2014 Oct 21;12:182
pubmed: 25567363
J Clin Invest. 1955 Sep;34(9):1345-53
pubmed: 13252080
Clin Chim Acta. 1996 Mar 15;246(1-2):59-76
pubmed: 8814971
Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):179-84
pubmed: 7749823
Clin Nutr. 2014 Aug;33(4):596-602
pubmed: 24315622
BMJ. 2011 Feb 22;342:d636
pubmed: 21343206
Clin Liver Dis. 2012 Nov;16(4):667-85
pubmed: 23101976
Nutr Res Pract. 2018 Apr;12(2):166-172
pubmed: 29629034
Public Health Nutr. 2021 Oct;24(14):4582-4590
pubmed: 33168121
Biochemistry. 1988 Mar 22;27(6):1901-7
pubmed: 3132203
J Lipid Res. 2006 Mar;47(3):515-20
pubmed: 16327022
Antioxidants (Basel). 2021 Feb 01;10(2):
pubmed: 33535459
J Lipid Res. 1979 Mar;20(3):289-315
pubmed: 87483
Mol Metab. 2018 Sep;15:45-55
pubmed: 29858147
Int J Vasc Med. 2012;2012:862504
pubmed: 21961068
Biochem Cell Biol. 2016 Aug;94(4):337-45
pubmed: 27487295
Biomolecules. 2020 Jul 01;10(7):
pubmed: 32630283